Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000255 · ClinicalTrials.gov registry record · Phase 2
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00000255 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 10 participants.
The verdict
NCT00000255, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine differential acute tolerance development to effects of nitrous oxide in humans.
Interventions
- DRUG Nitrous oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1995-04 |
| Est. Completion | 1996-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000255
The ClinicalTrials.gov registry entry for NCT00000255 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitrous oxide is the first listed.
NCT00000255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000255 about?
NCT00000255 is a clinical study titled "Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine differential acute tolerance d...
What is the current status of trial NCT00000255?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 1995-04. Estimated completion is 1996-05.
What interventions are being tested in trial NCT00000255?
The interventions under investigation include: Nitrous oxide (DRUG).
Who is sponsoring clinical trial NCT00000255?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.